Carcinoma

Hypoxic sensitizer and cytotoxin for head and neck cancer.

Abstract: Tumour hypoxia is well recognised as a major factor contributing to radioresistance. This article examines the role of hypoxia in influencing the treatment outcome following radiotherapy (RT), and reviews the rationale and results of clinical trials that...

Archives

Categories